Bortezomib will raise the amount or result of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Elevated flibanserin adverse outcomes could manifest if coadministered with a number of weak CYP3A4 inhibitors. chloramphenicol will improve the degree or effect of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Chec... https://deansfkor.blogdigy.com/the-ultimate-guide-to-urolithin-a-40559145